Various other cancer xenograft models have shown that HGF/SF-MET signaling enhances cancer invasion and metastasis, while inhibition of such signaling leads to reduced invasive potential and metastasis (Bardelli et al., 1998; Jeffers et al., 1998; Gallego et al., 2003). The gene discussed is HGF; the disease is cancer.